What Hangzhou Diagens Biotechnology Does & How It Makes Money (2526.HK)
Updated October 2026 · reflects Hangzhou Diagens Biotechnology's latest reported financials
Chinese maker of AI-powered chromosome analysis and lab imaging systems. It earns revenue mainly from selling medical imaging software, automated lab devices, reagents and consumables.
How Hangzhou Diagens Biotechnology makes money
It earns revenue mainly from selling medical imaging software, automated lab devices, reagents and consumables. Additional income comes from technology licensing, analysis and consulting services, and localized AI computing solutions and a cloud AI platform.
What Hangzhou Diagens Biotechnology does
Hangzhou Diagens Biotechnology, founded in 2016 and based in Hangzhou, China, specializes in AI-assisted medical imaging for cytogenetics. Its core product, AI AutoVision, automates chromosome karyotype analysis for genetics and hematologic oncology, while the MetaSight scanner automates microscopic imaging of chromosome and cell samples for uses including genetic health, radiation health and hemato-oncology. The company also covers the lab workflow before analysis through its KayoFlow line of cell harvesters, slide preparation and staining systems, and integrated workflow systems, along with reagents and consumables. Beyond hardware and software sales, it earns revenue from technology licensing, analysis and consulting services, localized AI storage, computing, training and inference solutions, and its cloud-based iMed MaaS medical imaging AI platform.
Products & services
- AI AutoVision chromosome karyotype analysis system
- MetaSight automatic cell microscopic image scanning system
- KayoFlow automatic cell harvester
- KayoFlow slide preparation and staining system
- iMed MaaS medical imaging AI platform
- Laboratory reagents and consumables
What is Hangzhou Diagens Biotechnology worth?
A reliable owner-earnings fair value isn't available for this company yet — we'd rather say so than print a number we don't trust.
We show a fair value only when the method is trustworthy. See Hangzhou Diagens Biotechnology on TacticScale →
Related companies
Dian Diagnostics (300244.SZ) · Autobio Diagnostics (603658.SS) · Shenzhen New Industries Biomedical Engineering (300832.SZ) · Danaher (DHR) · BGI Genomics (300676.SZ)
TacticScale